Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Terminated 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Advanced Solid Tumors 483Solid Tumor 446Advanced Solid Tumor 414Unspecified Adult Solid Tumor, Protocol Specific 362Solid Tumors 336Mesothelioma, Malignant 324Mesothelioma 289Solid Tumor, Adult 124Carcinoma, Non-Small-Cell Lung 122Retinoblastoma 117Lung Neoplasms 77Ovarian Neoplasms 75Melanoma 65Sarcoma 62Carcinoma, Renal Cell 59Stomach Neoplasms 58Pancreatic Neoplasms 58Neoplasms 53Esophageal Neoplasms 53Small Cell Lung Carcinoma 52Colorectal Neoplasms 52Hematopoietic and Lymphatic System Neoplasm 50Uterine Cervical Neoplasms 46Breast Neoplasms 46Solid Tumours 35Neoplasm Metastasis 35Advanced or Metastatic Solid Tumors 35Squamous Cell Carcinoma of Head and Neck 34Carcinoma, Hepatocellular 32Triple Negative Breast Neoplasms 31

Interventions

atezolizumab 1Nivolumab 1NVP-BKM120 1Injections 1E7046 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Locally Advanced Solid Tumor × Other solid neoplasm × Clear all
NCT06534190 2026-02-09

CD8 PET Imaging in Metastatic Solid Tumours

University Medical Center Groningen

Phase 2 Recruiting
30 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Completed
47 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT04084366 2025-03-26

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

OBI Pharma, Inc

Phase 1/2 Terminated
44 enrolled 15 charts
Other solid neoplasm

Locally Advanced Solid Tumor

NCT06658353 2025-03-20

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Jiangsu vcare pharmaceutical technology co., LTD

Phase 3 Recruiting
54 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT06349408 2025-01-27

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Recruiting
250 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡